Evidence map›Paper›PMID 37294374›Full record

SynthesisNeurosurgical review2023

Impact of extent of resection and postoperative radiotherapy on survival outcomes in intracranial solitary fibrous tumors: a systematic review and meta-analysis.

Sae Min Kwon, Min Kyun Na, Kyu-Sun Choi, Tae Ho Lim, Hyungoo Shin, Juncheol Lee, Heekyung Lee, Wonhee Kim, Youngsuk Cho, Jae Guk Kim and 2 more

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Neurosurgical review, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Systemic Therapy for Solitary Fibrous Tumor.Current treatment options in oncology · 2026
    Review
  6. Article
  7. Article
  8. Solitary fibrous tumor in the pineal region: A series of 5 cases and literature review.Journal of neuropathology and experimental neurology · 2025
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Sae Min Kwon *Department of Neurosurgery, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
Min Kyun Na *Department of Neurosurgery, College of Medicine, Hanyang University, Seoul, Korea.
Kyu-Sun ChoiDepartment of Neurosurgery, College of Medicine, Hanyang University, Seoul, Korea.
Tae Ho LimDepartment of Emergency Medicine, College of Medicine, Hanyang University, Seoul, Korea.
Hyungoo ShinDepartment of Emergency Medicine, College of Medicine, Hanyang University, Seoul, Korea.
Juncheol LeeDepartment of Emergency Medicine, College of Medicine, Hanyang University, Seoul, Korea.
Heekyung LeeDepartment of Emergency Medicine, College of Medicine, Hanyang University, Seoul, Korea.
Wonhee KimDepartment of Emergency Medicine, College of Medicine, Hallym University, Chuncheon, Korea.
Youngsuk ChoDepartment of Emergency Medicine, College of Medicine, Hallym University, Chuncheon, Korea.
Jae Guk KimDepartment of Emergency Medicine, College of Medicine, Hallym University, Chuncheon, Korea.
Chiwon AhnDepartment of Emergency Medicine, College of Medicine, Chung-Ang University, Seoul, Korea.
Bo-Hyoung JangDepartment of Preventive Medicine, College of Korean Medicine, Kyung Hee University, 26 Kyungheedae-Ro, Dongdaemun-Gu, Seoul, Republic of Korea, 02447. bhjang@khu.ac.kr.ORCID http://orcid.org/0000-0002-2141-3483
Hanyang University · KRHallym University · KRChung-Ang University · KRKeimyung University Dongsan Medical Center · KRKyung Hee University · KR

Funding

KoreanNational Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) No. 2020R1G1A1013289
6 · The paper itself

Abstract

The knowledge of optimal treatments for patients with intracranial solitary fibrous tumor (SFT) is limited, with inconclusive results from previous studies. In this study, we conducted a meta-analysis of relevant studies to identify the prognostic impact of the extent of resection (EOR) and postoperative radiotherapy (PORT) on survival outcomes of patients with intracranial SFT. We searched the Medline, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) to identify relevant studies published till April 2022. Progression-free survival (PFS) and overall survival (OS) were the outcomes of interest. Differences between two cohorts (gross total resection [GTR] vs. subtotal resection [STR] and PORT vs. surgery only) were estimated by calculating hazard ratios. Twenty-seven studies were selected for the meta-analysis, including data of 1348 patients (GTR, n = 819 vs. STR, n = 381 and PORT, n = 723 vs. surgery only, n = 578). Pooled hazard ratios of PFS (1, 3, 5, and 10 years) and OS (3, 5, and 10 years) revealed that the GTR cohort showed sustained superiority over the STR cohort. In addition, the PORT cohort was superior to the surgery-only cohort with respect to all PFS periods. Although the 10-year OS between the two cohorts was not statistically different, PORT showed significantly better 3- and 5-year OS than surgery only. The study findings suggest that GTR and PORT provide significant benefits for PFS and OS. Aggressive surgical resection of tumors to achieve GTR followed by PORT should be implemented as optimal treatments for all patients with intracranial SFT when feasible.

Indexed as

HemangiopericytomaSolitary Fibrous TumorsHumansPrognosisProgression-Free SurvivalRetrospective StudiesGross total resectionHemangiopericytomaRadiotherapy, AdjuvantSolitary fibrous tumorsSurvival

Identifiers

PMID37294374
OpenAlexW4379966870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.